tiprankstipranks
Histogen Inc. (GB:0A8J)
LSE:0A8J

Histogen (0A8J) Income Statement

0 Followers

Histogen Income Statement

Last quarter (Q2 2023), Histogen's total revenue was $5.00K, a decrease of 0.00% from the same quarter last year. In Q2, Histogen's net income was $-2.09M. See Histogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 19.00K$ 3.77M$ 1.03M$ 2.06M$ 11.30M
Cost of Revenue
$ -61.00K$ -61.00K$ 220.00K$ 968.00K$ 2.21M
Gross Profit
$ 19.00K$ 3.77M$ 812.00K$ 1.09M$ 9.09M
Operating Expense
$ 6.20M$ -14.41M$ 16.27M$ 12.80M$ 10.16M
Operating Income
$ -12.13M$ -10.64M$ -15.46M$ -11.71M$ -1.07M
Net Non Operating Interest Income Expense
$ -1.00K$ -1.00K$ -10.00K$ -64.00K$ 42.00K
Other Income Expense
$ -1.00K-$ -458.00K$ -7.04M$ -1.97M
Pretax Income
$ -12.13M$ -10.64M$ -15.01M$ -18.82M$ -3.00M
Tax Provision
$ -783.00K$ -783.00K---
Earnings From Equity Interest Net Of Tax
$ 1.00K----
Net Income Common Stockholders
$ -12.12M$ -11.11M$ -14.95M$ -18.77M$ -2.97M
Basic EPS
$ -4.76$ -3.46-$ -41.60$ -0.25
Diluted EPS
$ -3.20$ -3.46$ -7.80$ -41.60$ -0.25
Basic Average Shares
$ 15.31M$ 3.21M$ 1.92M$ 450.92K$ 11.81M
Diluted Average Shares
$ 15.31M$ 3.21M$ 1.92M$ 450.92K$ 11.81M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 6.14M$ -14.47M$ 16.49M$ 13.77M$ 12.37M
Net Income From Continuing And Discontinued Operation
$ -12.12M$ -10.62M$ -14.95M$ -18.77M$ -2.97M
Normalized Income
$ -5.25M--$ -11.63M$ -992.00K
Interest Expense
$ 1.00K--$ 64.00K-
EBIT
$ -12.13M$ -10.64M$ -15.01M$ -18.75M$ -1.07M
EBITDA
$ -12.08M$ -10.54M$ -14.91M$ -18.66M$ -924.00K
Currency in USD

Histogen Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis